Tell Congress to Abolish Retroactive DIR Fees
The Minnesota legislature cannot enact laws regulating DIR fees under Medicare Part D. Only the US Congress can act.
From the National Community Pharmacists Association: Over the past eight weeks, independent pharmacists have sent thousands of messages to Congressional offices urging support for DIR legislation. With less than two weeks before Congress returns to Washington, it is imperative that they hear this message at home! Call your members today!
If you have not yet done so, PLEASE CALL the district offices of your US Senators and Congressional Representatives and urge them to support legislation to ban retroactive DIR fees (S. 3308/H.R. 5951, the Improving Transparency and Accuracy in Medicare Part D Spending Act). You can find out who represents you in Washington, DC, and their contact information at http://www.whoismyrepresentative.com/
Support is growing for action on DIR fees! S. 3308 now has 9 co-sponsors and H.R. has 23. Furthermore, the NCPA House of Delegates approved a resolution at the NCPA’s Annual Convention stating, “NCPA opposes any retroactive reduction in payment directly or indirectly on clean claims submitted by pharmacies.”
Please call your legislators and urge them join the growing support for S. 3308/H.R. 5951 because:
These fees are often non-transparent and charged weeks or months after you have filled a prescription.
The financial uncertainty surrounding these fees impedes your ability to make financial decisions for your pharmacy.
The bill does not interfere with the PBMs’ ability to offer pay-for-performance incentives.
The legislation is a stronger response to DIRs than Medicare’s proposed DIR guidance and is necessary even if the guidance is finalized.
Provide examples of how DIR fees have impacted your pharmacy and your patients.
Thank you for your action on this important issue. Read more at the NCPA website.